References
- Frank RG, Huskamp HA, Rosenthal MB. Prescription Drug Policy Issues in California. ( Report prepared for the California HealthCare Foundation, April 1999).
- Wilkes MS, Bell RA, Kravitz RL. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff. 2000;19(2):110–128. doi:10.1377/hlthaff.19.2.110
- Mansfield PR, Mintzes B, Richards D, Toop L. Direct to consumer advertising. BMJ. 2004;330(7481):5–6. doi:10.1136/bmj.330.7481.5
- Wang B, Kesselheim AS. The role of direct-to-consumer pharmaceutical advertising in patient consumerism. Virtual Mentor. 2013;15(11):960–965. doi:10.1001/virtualmentor.2013.15.11.pfor1-1311
- Gellad ZF, Lyles KW. Direct-to-consumer advertising of pharmaceuticals. Am J Med. 2007;120(6):475–480. doi:10.1016/j.amjmed.2006.09.030
- Donohue J. A history of drug advertising: the evolving roles of consumers and consumer protection. Milbank Q. 2006;84(4):659–699. doi:10.1111/milq.2006.84.issue-4
- Mathur MB, Gould M, Khazeni N. Direct-to-consumer drug advertisements can paradoxically increase intentions to adopt lifestyle changes. Front Psychol. 2016;7:1533. doi:10.3389/fpsyg.2016.01533
- Mackey TK, Cuomo RE, Liang BA. The rise of digital direct-to-consumer advertising?: comparison of direct-to-consumer advertising expenditure trends from publicly available data sources and global policy implications. BMC Health Serv Res. 2015;15(1):236. doi:10.1186/s12913-015-0885-1
- Langreth R. Three drug makers, helped by ads, post higher profits. Wall Street Journal. 1997 Oct 22.
- Maguire P. How direct-to-consumer advertising is putting the squeeze on physicians. ACP/ASIM Observer. 1999;1:24–25.
- Mintzes B, Barer ML, Kravitz RL, et al. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. CMAJ. 2003;169(5):405–412.
- Dave D. Direct-to-consumer advertising in pharmaceutical markets: effects on demand and prices. Available from: https://voxeu.org/article/consumer-adverts-pharmaceuticals-impact-prices-and-sales. Accessed December 17, 2019.
- Rosenthal MB, Berndt ER, Donohue JM, et al. Demand effects of recent changes in prescription drug promotion. Forum Health Econ Policy. 2003;6(1):1044. doi:10.2202/1558-9544.1044
- Gilbody S, Wilson P, Watt I. Benefits and harms of direct to consumer advertising: a systematic review. Qual Saf Health Care. 2005;14(4):246–250. doi:10.1136/qshc.2004.012781
- Polen HH, Khanfar NM, Clauson KA. Impact of direct-to-consumer advertising (DTCA) on patient health-related behaviors and issues. Health Mark Q. 2009;26(1):42–55. doi:10.1080/07359680802473521
- Bradford WD, Kleit AN, Nietert PJ, Ornstein S. Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals. Clin Ther. 2006;28(12):2105–2118. doi:10.1016/j.clinthera.2006.12.015
- Calfee J, Winston C, Stempski R. Direct‐to‐consumer advertising and the demand for cholesterol‐reducing drugs. J Law Econ. 2002;45(S2):673–690. doi:10.1086/374704
- Deshpande A, Menon A, Perri M, Zinkhan G. Direct-to-consumer advertising and its utility in health care decision making: a consumer perspective. J Health Commun. 2004;9:499–513. doi:10.1080/10810730490523197
- Al-Haddad MS, Hamam F, Al-Shakhshir SM. General public knowledge, perceptions and practice towards pharmaceutical drug advertisements in the Western region of KSA. Saudi Pharm J. 2014;22(2):119–126. doi:10.1016/j.jsps.2013.03.002
- Bonaccorso SN, Sturchio JL. For and against. Direct to consumer advertising is medicalising normal human experience. BMJ. 2002;324(7342):908–911. doi:10.1136/bmj.324.7342.910
- El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63(6):871–880. doi:10.1136/gutjnl-2012-304269
- MacFarlane B. Management of gastroesophageal reflux disease in adults: a pharmacist’s perspective. Integr Pharm Res Pract. 2018;7:41–52. doi:10.2147/IPRP.S142932
- Hrelja N, Zerem E. Proton pump inhibitors in the management of gastroesophageal reflux disease. Med Arch. 2011;65:52–55.
- Savarino V, Di Mario F, Scarpignato C. Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety. Pharmacol Res. 2009;59(3):135–153. doi:10.1016/j.phrs.2008.09.016
- Morris NS, MacLean CD, Chew LD, Littenberg B. The single item literacy screener: evaluation of a brief instrument to identify limited reading ability. BMC Fam Pract. 2006;7(1):21. doi:10.1186/1471-2296-7-21
- Al-Jumaili AA, Al-Rekabi MD, Sorofman B. Evaluation of instruments to assess health literacy in Arabic language among Iraqis. Res Social Adm Pharm. 2015;11(6):803–813. doi:10.1016/j.sapharm.2015.02.002
- World Medical Association. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194. doi:10.1001/jama.2013.281053.
- Foley L, Gross D. Are consumers well informed about prescription drugs? The impact of printed direct-to-consumer advertising. American Association of Retired Persons; 2010. Available from: https://assets.aarp.org/rgcenter/health/2000_04_advertising.pdf. Accessed December 21, 2019.
- PhRMA Guiding Principles. Direct to consumer advertisements about prescription medicines; 2018 Available from: https://www.phrma.org/-/media/Project/PhRMA/PhRMA-Org/PhRMA-Org/PDF/PhRMA_Guiding_Principles_2018.pdf. Accessed December 21, 2019.
- U.S. Food and Drug Administration. Code of federal regulations title 21; 2019. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=202.1. Accessed December 22, 2019.
- Klara K, Kim J, Ross JS. Direct-to-consumer broadcast advertisements for pharmaceuticals: off-label promotion and adherence to FDA guidelines. J Gen Intern Med. 2018;33(5):651–658. doi:10.1007/s11606-017-4274-9
- Korenstein D, Keyhani S, Mendelson A, Ross JS, Thiem U. Adherence of pharmaceutical advertisements in medical journals to FDA guidelines and content for safe prescribing. PLoS One. 2011;6(8):e23336. doi:10.1371/journal.pone.0023336
- Faerber AE, Kreling DH. Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs. J Gen Intern Med. 2014;29(1):110–118. doi:10.1007/s11606-013-2604-0
- Sweet M. Website launched to expose “tricks” of drug ads. BMJ. 2003;327(7420):936. doi:10.1136/bmj.327.7420.936
- Hwang MJ, Young HN. Enhancing the educational value of direct-to-consumer advertising of prescription drugs. J Am Pharm Assoc. 2003;57(5):571–578. doi:10.1016/j.japh.2017.05.008
- Donohue JM, Cevasco M, Rosenthal MB. A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med. 2007;357(7):673–681. doi:10.1056/NEJMsa070502